(Q41675929)

6 October 2017

title

Erythropoietin in diabetic macular edema and renal insufficiency (English)

1 reference

6 October 2017

1 reference

diabetic macular edema

1 reference

E. A. Friedman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7611253

17 June 2024

C. D. Brown

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7611253

17 June 2024

D. H. Berman

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7611253

17 June 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7611253

17 June 2024

publication date

1 July 1995

1 reference

full work available at URL

6 October 2017

https://api.elsevier.com/content/article/PII:0272638695901752?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90175-2

https://api.elsevier.com/content/article/PII:0272638695901752?httpAccept=text/plain

17 June 2024

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90175-2

American Journal of Kidney Diseases

17 June 2024

published in

1 reference

6 October 2017

volume

26

1 reference

6 October 2017

issue

1

1 reference

6 October 2017

page(s)

202-208

1 reference

Lilly Lecture 1993. Glycation and diabetic complications

6 October 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90175-2

Growth factors in the pathogenesis of renovascular complications of diabetes mellitus

17 June 2024

2

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90175-2

Angiotensin converting enzyme inhibition prevents development of muscle and nerve dysfunction and stimulates angiogenesis in streptozotocin-diabetic rats

17 June 2024

3

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90175-2

Familial, hemodynamic and metabolic factors in the predisposition to diabetic kidney disease

17 June 2024

4

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90175-2

Hyperglycemic pseudohypoxia and diabetic complications.

17 June 2024

5

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90175-2

Partial absorption of hard exudates in patients with diabetic end-stage renal disease and severe anemia after treatment with erythropoietin

17 June 2024

7

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90175-2

Measurement of viscosity of biologic fluids by cone plate viscometer

17 June 2024

8

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90175-2

Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial

17 June 2024

10

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90175-2

Does treatment of predialysis patients with recombinant human erythropoietin compromise renal function?

17 June 2024

12

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90175-2

background diabetic retinopathy

17 June 2024

13

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90175-2

Diabetic maculopathy. A critical review highlighting diffuse macular edema

17 June 2024

14

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90175-2

Diabetic macular edema. A review

17 June 2024

16

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90175-2

A three-year trial of atromid therapy in exudative diabetic retinopathy

17 June 2024

17

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90175-2

The effects of lipid lowering on diabetic retinopathy

17 June 2024

18

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90175-2

On the pathogenesis of diabetic retinopathy. A 1990 update

17 June 2024

19

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90175-2

17 June 2024

Diseases of the retina

20

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90175-2

Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth

17 June 2024

21

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90175-2

Alloxan diabetes alters the rabbit transarterial wall oxygen gradient

17 June 2024

0 references

Resistance to ischaemic conduction failure in chronic hypoxaemia and diabetes

24

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90175-2

Effect of hyperbaric oxygenation on normal and chronic streptozotocin diabetic peripheral nerves

17 June 2024

25

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90175-2

Increased susceptibility to hypoxia of prolonged action potential duration in ventricular papillary muscles from diabetic rats

17 June 2024

27

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90175-2

Plasma erythropoietin activity in diabetes patients, studied by determining the 59Fe incorporation in posthypoxic polycythemic mice

17 June 2024

28

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90175-2

Deficiency of erythropoietin is not responsible for the anaemia associated with cyclosporin treatment of insulin-dependent diabetes mellitus. Canadian-European Randomized Control Trial Group

17 June 2024

29

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90175-2

The linked roles of nitric oxide, aldose reductase and, (Na+,K+)-ATPase in the slowing of nerve conduction in the streptozotocin diabetic rat.

17 June 2024

30

1 reference

https://api.crossref.org/works/10.1016/0272-6386(95)90175-2

17 June 2024

Identifiers

1 reference

release_tt72iitiqjhhxgn3tnxcg2dav4

6 October 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/tt72iitiqjhhxgn3tnxcg2dav4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference